Key Development Speaking at the 30th Anniversary Ceremony of the Drug Administration of Vietnam (Ministry of Health) on August 7,... Read more
Category: Uncategorized
Healthcare Import Modernization: Ministry of Health Issues Standardized Framework for State Food Safety Inspections on Imported Goods
Key Development To resolve operational bottlenecks during customs clearance and ensure consistent enforcement of state food safety regulations, Dr. Chu... Read more
Resolving Pharmaceutical Licensing Bottlenecks: Ministry of Health Issues Comprehensive Circular Implementing Amended Pharmaceutical Law 2024 on Marketing Authorizations, Innovator Brand Classifications, and OTC Standards
Key Development This morning, August 10, 2026, the Ministry of Health (MOH) of Vietnam officially promulgated a landmark Circular detailing... Read more
Resolving Pharmaceutical Licensing Bottlenecks: Ministry of Health Issues Comprehensive Circular Implementing Amended Pharmaceutical Law 2024 on Marketing Authorizations, Innovator Brand Classifications, and OTC Standards
Key Development This morning, August 10, 2026, the Ministry of Health (MOH) of Vietnam officially promulgated a landmark Circular detailing... Read more
Historic Vaccine Milestone: US FDA Grants Approval for Moderna’s mFLUSIVA® – The World’s First mRNA-Based Seasonal Influenza Vaccine
Key Development The U.S. Food and Drug Administration (FDA) has granted regulatory approval for mFLUSIVA® (mRNA-1010), developed by Moderna, Inc.... Read more
Outbreak Diagnostic Response: Roche Launches Two Novel PCR Cyclospora Test Panels as U.S. Foodborne Outbreak Escalates to Record Levels
Key Development Swiss healthcare giant Roche Holding AG (SIX: ROG) officially announced the commercial availability of two new PCR-based diagnostic... Read more
Consumer Health & Wellness M&A: Procter & Gamble (P&G) Executes $3.8 Billion Acquisition of Premium Supplement Brand Thorne HealthTech
Key Development Consumer goods giant Procter & Gamble Co. (NYSE: PG) has entered into a definitive agreement to acquire premium... Read more
HIV & PrEP Commercial Acceleration: Gilead Sciences Outperforms Q2 2026 Revenue Estimates at $7.8 Billion, Offsetting One-Time M&A Charges
Key Development American biopharmaceutical major Gilead Sciences, Inc. (NASDAQ: GILD) officially released its Q2 2026 financial readouts, generating total quarterly... Read more
Anti-Obesity Franchise Market Dynamics: Novo Nordisk Raises 2026 Outlook, Yet Shares Fall 6% as Oral Wegovy Sales Miss Consensus and CagriSema Trial Disappoints
Key Development Danish biopharmaceutical leader Novo Nordisk (OMX: NOVOb) released its Q2 2026 financial readouts, officially raising its full-year 2026... Read more









